Lexeo Therapeutics (LXEO) Capital Leases (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Capital Leases of $95,000 for Q2 2026, down 83.5% from $577,000 a year earlier and down 52.0% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Capital Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Lexeo Therapeutics posted Capital Leases of $327,000, down 60.0% from FY2024.
- Capital Leases has declined for three consecutive years, with a three-year compound annual growth rate of -41.7% (FY2022 to FY2025).
- By year, Capital Leases came in at $817,000 in FY2024 (-34.5%), $1.25 million in FY2023 (-24.3%) and $1.65 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Capital Leases in data going back to Q4 2022.
- Year over year, Capital Leases has now declined in each of the last eight quarters, with an average decline of 52.0% over the last eight quarters.
- Across the past five years, year-over-year decline in Capital Leases ran from 24.3% in Q4 2023 to 83.5% in Q2 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at $198,000 (Q1 2026), $327,000 (Q4 2025) and $454,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Lexeo Therapeutics | 248.75 Mn | -411.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95,000.00 |
| Mar 31, 2026 | 198,000.00 |
| Dec 31, 2025 | 327,000.00 |
| Sep 30, 2025 | 454,000.00 |
| Jun 30, 2025 | 577,000.00 |
| Mar 31, 2025 | 698,000.00 |
| Dec 31, 2024 | 817,000.00 |
| Sep 30, 2024 | 930,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.65 Mn |
API Access
Lexeo Therapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();